Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells.

Abstract

BACKGROUND:

Taxol is the most commonly used agent for salvage chemotherapy in transitional cell carcinoma of the urothelium. We examined mechanisms responsible for taxol resistance by using T24 human bladder carcinoma cells.

MATERIALS AND METHODS:

We used an inhibitor and an activator of the phosphatidylinositol-3 kinase-Akt pathway in cell survival and caspase-3 assays, an HPLC method for determining released cytochrome c and immunoblotting for detecting protein phosphorylation.

RESULTS:

Activation of Akt increased paclitaxel resistance by increasing Bad phosphorylation, leading to decreased release of mitochondrial cytochrome c and caspase-3-mediated apoptosis. On the other hand, inhibition of Akt prevented paclitaxel resistance by enhancing the effects of paclitaxel on Bad phosphorylation, mitochondrial cytochrome c release and caspase-3-mediated apoptosis, besides diminishing or abolishing the opposing effects of Akt activation.

CONCLUSION:

Akt-mediated Bad phosphorylation plays an important role in preservation of mitochondrial membrane systems leading to paclitaxel resistance in T24 cells.

• Authors: Arpad Szanto, Zita Bognar, Andras Szigeti, Aliz Szabo, Laszlo Farkas, Ferenc Gallyas Jr
• Journal: Anticancer research (Anticancer Res) Vol. 29 Issue 1 Pg. 159-64 (Jan 2009) ISSN: 0250-7005 [Print] Greece
• PMID: 19331146 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents, Phytogenic
• BAD protein, human
• Chromones
• Morpholines
• bcl-Associated Death Protein
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
• Cytochromes c
• Phosphatidylinositol 3-Kinases
• Oncogene Protein v-akt
• Caspase 3
• Paclitaxel

Topics

• Antineoplastic Agents, Phytogenic (pharmacology)
• Carcinoma, Transitional Cell (drug therapy, enzymology, metabolism)
• Caspase 3 (metabolism)
• Chromones (pharmacology)
• Cytochromes c (metabolism)
• Drug Resistance, Neoplasm
• Enzyme Activation
• Humans
• Mitochondrial Membranes (enzymology, metabolism)
• Morpholines (pharmacology)
• Oncogene Protein v-akt (antagonists & inhibitors, metabolism)
• Paclitaxel (pharmacology)
• Phosphatidylinositol 3-Kinases (metabolism)
• Phosphorylation
• Urinary Bladder Neoplasms (drug therapy, enzymology, metabolism)
• bcl-Associated Death Protein (metabolism)